Replies to post #466858 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Nope.

Not really expecting results at all. But if they do happen I expect a heavy does of hiding the randomized endpoints. They do not even have the original primary as endpoint at all, so you can be certain we will not see that,

Further, I expect the original endpoint of OS between the randomized arms also failed. And that is the "gold standard".

If so it will hardly be unambiguous.

[RobotDroid]

I am in both, and it's MUCH more certain here than with CVM as far as timetables, but in the end, both will be a good cancer killing drugs...hopefully. Maybe a DVax MK combo trial in the future..

[The Danish Dude]

$CVM is not $NWBO

Looking at $NWBO's setup and progress during data lock, puts NWBO in its own league. Patience in turning each stone and tackling all hurdles on the way to avoid being a part of the 97% failures in Oncology trials.

Everything points to unambigous results and delivering it in style.

I'm very glad we have Linda Powers at the rudder.